Marshall Wace
SRTAW

Marshall Wace’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Marshall Wace’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-166,666
Closed -$219K – 1882
2020
Q3 		$203K Buy
+166,666
New +$180K ﹤0.01% 1453

Other funds holding SRTAW

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return

Marshall Wace's SRTAW Position: Q4 2020 in Review

Marshall Wace sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q4 2020, closing a stake of 166,666 shares — an estimated $219K sold.

Marshall Wace first reported a position in SRTAW in Q3 2020 and held it in 1 quarter. The position peaked at $203K in Q3 2020. 17 funds tracked by Wall St. Rank hold SRTAW as of Q4 2020.

  • Marshall Wace reported no remaining Strata Critical Medical Inc Warrants position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace sold 166,666 Strata Critical Medical Inc Warrants shares in Q4 2020, an estimated $219K.
  • Marshall Wace first reported a position in Strata Critical Medical Inc Warrants in Q3 2020 and held it in 1 quarter.
  • Marshall Wace's Strata Critical Medical Inc Warrants position peaked at $203K in Q3 2020.
  • 17 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q4 2020.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.